Immunomodulator Market Growth Rate, Latest Trends, Industry Insights And Forecast To 2033

"The new report published by The Business Research Company, titled Immunomodulator Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the immunomodulator market size has grown strongly in recent years. It will grow from $204.37 billion in 2023 to $219.94 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The immunomodulator market size is expected to see strong growth in the next few years. It will grow to $297.15 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15591&type=smp

Rise In Chronic Diseases Fueling The Growth Of The Immunomodulator Market
The rise in chronic diseases is expected to propel the growth of the immunomodulator market. Chronic diseases are long-lasting medical conditions that typically develop gradually over time and persist for extended periods, often lasting for years or even a lifetime. Chronic diseases are becoming more common due to a multitude of interconnected variables, such as an aging population, lifestyle decisions, genetic predispositions, and the accessibility and infrastructure of healthcare. Immunomodulators provide valuable therapeutic options for managing chronic diseases by modulating immune responses, reducing inflammation, preventing organ rejection, enhancing immune surveillance, and improving symptom control. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rise in chronic diseases is driving the growth of the immunomodulator market.

Innovative Non-Immunosuppressive Immunomodulators Lead Revenue Growth In Major Companies
Companies operating in the immunomodulator market are focused on the development of non-immunosuppressive products to address the growing demand for treatments that offer targeted immune modulation without compromising the body's overall immune function. Non-immunosuppressive refers to treatments or substances that do not suppress or weaken the immune system's response. For instance, in February 2024, Nuvig Therapeutics, Inc., a US-based biotechnology company, initiated early-stage clinical trials for NVG-2089, a next-generation immune modulator. NVG-2089 is a proprietary product designed to treat patients with inflammatory myopathies and severe dermatologic autoimmune diseases. The FDA has granted fast-track designation for NVG-2089's development in bullous pemphigoid. This novel, recombinant, non-immunosuppressive immunomodulator targets type II Fc receptors to trigger an endogenous regulatory mechanism that reduces autoimmune dysregulation. The study's primary objective is to assess the safety and tolerability of NVG-2089, with secondary objectives focusing on pharmacokinetics and pharmacodynamics.

The immunomodulator market covered in this report is segmented -

1) By Product Type: Immunosuppressants, Immunostimulants, Other Product Types
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distribution Channels
3) By Application: Oncology, Respiratory, Human Immunodeficiency Virus, Other Applications
4) By End-User: Hospitals, Clinics, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=15591&type=discount

Major companies operating in the immunomodulator market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Applied Molecular Genetics Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, UCB S.A., Horizon Therapeutics plc, Incyte Corporation, Ipsen SA, Kyowa Kirin Co. Ltd., Amicus Therapeutics Inc.

Contents of the report:
1. Executive Summary
2. Immunomodulator Market Report Structure
3. Immunomodulator Market Trends And Strategies
4. Immunomodulator Market - Macro Economic Scenario
5. Immunomodulator Market Size And Growth
…..
27. Immunomodulator Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/immunomodulator-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.